Dolby Laboratories, Inc. DLB Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $95.45M+77.8% | $53.68M+8.1% | $49.65M+6.7% | $46.54M-49.5% | $92.23M+35.5% | ||
| $24.1M-0.2% | $24.15M+9.8% | $22M+0.3% | $21.93M+1.8% | $21.54M-3.7% | ||
| $30.71M-17.5% | $37.21M+19.8% | $31.05M+1.1% | $30.73M+0.2% | $30.66M-15.0% | ||
| $5.2M+32,375% | $16K-99.9% | $14.13M+361% | -$5.41M-252% | $3.57M+149% | ||
| $2.9M+266% | $792K— | $0-100% | $615K-50.3% | $1.24M+69.5% | ||
| $21.13M-74.5% | $82.96M+146% | $33.7M+315% | -$15.65M— | —— | ||
| -$2.97M-238% | -$879K+78.0% | -$4M+22.7% | -$5.18M-307% | $2.5M+286% | ||
| $39.3M-9.8% | $43.58M-39.3% | $71.83M+194% | -$76.25M-439% | $22.46M+368% | ||
| $30.69M+874% | $3.15M— | —— | -$20.4M-56.3% | -$13.05M+3.5% | ||
| -$9.19M-203% | -$3.03M— | —— | —— | -$9.16M-156% | ||
| —— | $1.89M— | —— | $17.11M+947% | $1.63M+237% | ||
| $650K-90.5% | $6.83M+270% | -$4.02M+7.5% | -$4.34M-962% | -$409K-111% | ||
| -$10.46M-338% | $4.39M+110% | -$44.72M— | —— | —— | ||
| $2.75M+3.0% | $2.67M+3.5% | $2.58M+4.4% | $2.47M-14.6% | $2.89M+1.9% | ||
| $9.48M+511% | $1.55M+683% | -$266K+89.6% | -$2.56M+47.7% | -$4.88M-512% | ||
| —— | $5.28M— | —— | —— | $414K-54.6% | ||
| $92.51M+68.8% | $54.8M-55.4% | $122.83M+81.5% | $67.69M-61.3% | $174.9M+63.8% | ||
| $9.06M+95.8% | $4.63M-71.5% | $16.24M+153% | $6.43M-6.8% | $6.9M+1.7% | ||
| $0— | $0— | —— | —— | —— | ||
| —— | —— | —— | —— | $15.91M— | ||
| —— | $6.62M— | —— | —— | $0— | ||
| -$46.09M-3,802% | $1.25M+106% | -$21.91M-241% | -$6.43M-125% | $25.9M+418% | ||
| $34.34M0.0% | $34.34M+8.7% | $31.59M-0.1% | $31.63M-0.6% | $31.83M+0.9% | ||
| $65M-7.2% | $70.01M+100% | $35M-50.0% | $70.01M+100% | $35M+133% | ||
| $1.04M-92.7% | $14.25M+184% | $5.02M-60.1% | $12.56M+217% | $3.97M-82.1% | ||
| $559K+2.2% | $547K+37.4% | $398K-15.0% | $468K+94.2% | $241K-67.4% | ||
| -$99.88M+18.0% | -$121.83M-90.2% | -$64.06M-5.5% | -$60.74M+6.4% | -$64.87M-12.7% | ||
| -$301K-5,920% | -$5K— | —— | $5.7M— | —— | ||
| -$53.76M+18.3% | -$65.8M-279% | $36.8M+491% | $6.22M-95.5% | $138.69M+309% | ||
| $32.01M+175% | $11.65M-23.5% | $15.22M+1.7% | $14.97M-54.6% | $32.94M+210% | ||
| —— | —— | $0— | $0— | $0— | ||
| —— | $5.28M— | —— | —— | $414K-54.6% | ||
| $40.65M+105% | $19.82M+184% | -$23.58M+9.2% | -$25.96M-375% | $9.45M-59.7% | ||
| $9.48M+511% | $1.55M+683% | -$266K+89.6% | -$2.56M+47.7% | -$4.88M-512% | ||
| $12.37M+157% | $4.81M+72.5% | $2.79M+2,458% | $109K— | —— | ||
| -$9.19M-203% | -$3.03M— | —— | —— | -$9.16M-156% | ||
| $30.69M+874% | $3.15M— | —— | -$20.4M-56.3% | -$13.05M+3.5% | ||
| $2.75M+3.0% | $2.67M+3.5% | $2.58M+4.4% | $2.47M-14.6% | $2.89M+1.9% | ||
| —— | $1.89M— | —— | $17.11M+947% | $1.63M+237% | ||
| $2.9M+266% | $792K— | $0-100% | $615K-50.3% | $1.24M+69.5% | ||
| $37.03M+4,837% | $750K— | —— | —— | $0— | ||
| —— | —— | —— | —— | $15.91M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $65.25K0.0% | $65.25K0.0% | $65.25K0.0% | ||
| —— | —— | $0— | $0— | $0— | ||
| $1.03M-96.7% | $31.2M+1,398% | $2.08M+72.9% | $1.2M-20.3% | $1.51M-95.3% | ||
| —— | —— | $0— | $0— | $0— | ||
| —— | —— | $0— | $0— | $0— | ||
| —— | —— | $308.75K0.0% | $308.75K0.0% | $308.75K0.0% | ||
| $9.48M+511% | $1.55M+683% | -$266K+89.6% | -$2.56M+47.7% | -$4.88M-512% | ||
| $882K-76.9% | $3.81M+128% | -$13.57M-263% | $8.34M+968% | -$961K-129% | ||
| —— | —— | $0— | $0— | $0— | ||
| $83.44M+66.3% | $50.17M-52.9% | $106.59M+74.0% | $61.26M-63.5% | $168M+68.0% | ||
| $83.44M+66.3% | $50.17M-52.9% | $106.59M+74.0% | $61.26M-63.5% | $168M+68.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Dolby Laboratories, Inc.'s cash flow data come from?
- Every line is extracted from Dolby Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.